Vascular dysfunction in retinopathy-an emerging role for arginase

Area of Science:

• Ophthalmology
• Vascular Biology
• Biochemistry

Background:

• Retinal neovascularization is a major cause of vision impairment.
• It involves vascular inflammation, endothelial injury, and fibrosis, leading to retinal detachment.
• Understanding its mechanisms is crucial for effective prevention and treatment.

Purpose of the Study:

• To investigate the role of the urea/ornithine pathway enzyme arginase in retinal neovascularization.
• To explore the link between NOX2 NADPH oxidase and arginase activation in retinopathy.

Main Methods:

• Review of studies on peripheral vessels from diabetic animals and retinopathy models.
• Analysis of arginase activity, expression (arginase 1), oxidative stress, and nitric oxide bioavailability.
• Investigation of the effects of NOX2 knockout and NADPH oxidase inhibition.

Main Results:

• Increased arginase activity in diabetic vessels impairs endothelial function by reducing nitric oxide and increasing oxidative stress.
• Arginase activation promotes cell growth and fibrosis via polyamine and proline production.
• In retinopathy models, elevated oxidative stress and inflammation correlate with increased arginase activity and expression.
• Inhibiting or decreasing arginase blocks retinopathy progression.
• NOX2 knockout or NADPH oxidase inhibition prevents arginase induction in retinopathy.

Conclusions:

• NADPH oxidase-induced arginase pathway activation plays a critical role in retinal vascular dysfunction in retinopathy.
• Targeting arginase activity presents a potential therapeutic strategy for treating vision-threatening retinopathy.